A prospective study of serum adiponectin and regression of metabolic syndrome: The ARIRANG study

Biochemical and Biophysical Research Communications

Volumn 466, Issue 2, 2015, Pages 201-205

  Kim, Jang Young ^a,b   Yadav, Dhananjay ^a   Ahn, Song Vogue ^a,b   Koh, Sang Baek ^a,b  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Yonsei University Wonju   (South Korea)

Author keywords

Adipokine; Adiponectin; Insulin resistance; Metabolic syndrome; Prospective study

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; REMISSION; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

ADIPONECTIN; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84942293556     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.09.007     Document Type: Article

References (32)

1. Y. Okamoto, S. Kihara, T. Funahashi, Y. Matsuzawa, and P. Libby Adiponectin: a key adipocytokine in metabolic syndrome Clin. Sci. 110 2006 267 278
2. E.S. Ford Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence Diabetes Care 28 2005 1769 1778
3. S. Malik, N.D. Wong, S.S. Franklin, T.V. Kamath, G.J. L'Italien, J.R. Pio, and G.R. Williams Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults Circulation 110 2004 1245 1250
4. Y. Matsuzawa, T. Funahashi, S. Kihara, and I. Shimomura Adiponectin and metabolic syndrome Arterioscler. Thromb. Vasc. Biol. 24 2004 29 33
5. J.P. Whitehead, A.A. Richards, I.J. Hickman, G.A. Macdonald, and J.B. Prins Adiponectin-a key adipokine in the metabolic syndrome Diabetes. Obes. Metab. 8 2006 264 280
6. J.Y. Kim, S.V. Ahn, J.H. Yoon, S.B. Koh, J. Yoon, B.S. Yoo, S.H. Lee, J.K. Park, K.H. Choe, and E. Guallar Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study Diabetes Care 36 2013 1547 1553
7. C.E. Juge-Aubry, E. Henrichot, and C.A. Meier Adipose tissue: a regulator of inflammation Best. Pract. Res. Clin. Endocrinol. Metab. 19 2005 547 566
8. P.A. Kern, G.B. Di Gregorio, T. Lu, N. Rassouli, and G. Ranganathan Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression Diabetes 52 2003 1779 1785
9. S.B. Koh, J.K. Park, J.H. Yoon, S.J. Chang, S.S. Oh, J.Y. Kim, S.Y. Ryu, K.S. Kim, T.Y. Lee, and J.S. You Preliminary report: a serious link between adiponectin levels and metabolic syndrome in a Korean nondiabetic population Metab. Clin. Exp. 59 2010 333 337
10. S.B. Koh, J. Yoon, J.Y. Kim, B.S. Yoo, S.H. Lee, J.K. Park, and K.H. Choe Relationships between serum adiponectin with metabolic syndrome and components of metabolic syndrome in non-diabetic Koreans: ARIRANG study Yonsei Med. J. 52 2011 234 241
11. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, and S.C. Smith Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
12. S.Y. Lee, H.S. Park, D.J. Kim, J.H. Han, S.M. Kim, G.J. Cho, D.Y. Kim, H.S. Kwon, S.R. Kim, C.B. Lee, S.J. Oh, C.Y. Park, and H.J. Yoo Appropriate waist circumference cutoff points for central obesity in Korean adults Diabetes. Res. Clin. Pract. 75 2007 72 80
13. H.C. Chang, J.T. Horng, T.T. Chau, Y.W. Chen, C.F. Hsieh, C.W. Chang, and T.M. Hsiao Relationship between changes in components associated with metabolic syndrome and disappearance, or remission, of metabolic syndrome during 1 year J. Int. Med. Res. 40 2012 2311 2320
14. J.A. Morrison, C.J. Glueck, S. Daniels, P. Wang, and D. Stroop Paradoxically high adiponectin in obese 16-year-old girls protects against appearance of the metabolic syndrome and its components seven years later J. Pediatr. 158 2011 208 214
15. S. Lee, and H.B. Kwak Role of adiponectin in metabolic and cardiovascular disease J. Exerc. Rehabil. 10 2014 54 59
16. J. Spranger, A. Kroke, M. Mohlig, M.M. Bergmann, M. Ristow, H. Boeing, and A.F. Pfeiffer Adiponectin and protection against type 2 diabetes mellitus Lancet 361 2003 226 228
17. S. Shetty, C.M. Kusminski, and P.E. Scherer Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies Trends. Pharmacol. Sci. 30 2009 234 239
18. G. Fantuzzi Adipose tissue, adipokines, and inflammation, The Journal of allergy and clinical immunology J. Allergy. Clin. Immunol. 115 2005 911 919
19. H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, and M.J. Quon Adiponectin stimulates production of nitric oxide in vascular endothelial cells J. Biol. Chem. 278 2003 45021 45026
20. N. Ouchi, H. Kobayashi, S. Kihara, M. Kumada, K. Sato, T. Inoue, T. Funahashi, and K. Walsh Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells J. Biol. Chem. 279 2004 1304 1309
21. M.M. Swarbrick, and P.J. Havel Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans Metab. Syndr. Relat. Disord. 6 2008 87 102
22. S. Lee, and H.B. Kwak Effects of interventions on adiponectin and adiponectin receptors J. Exerc. Rehabil. 10 2014 60 68
23. A.D. Karelis, and R. Rabasa-Lhoret Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals Diabetes. Metab. 34 2008 183 184
24. V. Primeau, L. Coderre, A.D. Karelis, M. Brochu, M.E. Lavoie, V. Messier, R. Sladek, and R. Rabasa-Lhoret Characterizing the profile of obese patients who are metabolically healthy Int. J. Obes. 35 2011 971 981
25. C.A. Aguilar-Salinas, E.G. Garcia, L. Robles, D. Riano, D.G. Ruiz-Gomez, A.C. Garcia-Ulloa, M.A. Melgarejo, M. Zamora, L.E. Guillen-Pineda, R. Mehta, S. Canizales-Quinteros, M.T. Tusie Luna, and F.J. Gomez-Perez High adiponectin concentrations are associated with the metabolically healthy obese phenotype J. Clin. Endocrinol. Metab. 93 2008 4075 4079
26. M.S. Boyne, N.R. Bennett, R.S. Cooper, T.Y. Royal-Thomas, F.I. Bennett, A. Luke, R.J. Wilks, and T.E. Forrester Sex-differences in adiponectin levels and body fat distribution: longitudinal observations in Afro-Jamaicans Diabetes. Res. Clin. Pract. 90 2010 e33 36
27. H. Nishizawa, I. Shimomura, K. Kishida, N. Maeda, H. Kuriyama, H. Nagaretani, M. Matsuda, H. Kondo, N. Furuyama, S. Kihara, T. Nakamura, Y. Tochino, T. Funahashi, and Y. Matsuzawa Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein Diabetes 51 2002 2734 2741
28. J. Persson, L. Folkersen, J. Ekstrand, J. Helleberg, A. Gabrielsen, P. Lundman, U. Hedin, and G. Paulsson-Berne High plasma adiponectin concentration is associated with all-cause mortality in patients with carotid atherosclerosis Atherosclerosis 225 2012 491 496
29. J.M. Dekker, T. Funahashi, G. Nijpels, S. Pilz, C.D. Stehouwer, M.B. Snijder, L.M. Bouter, Y. Matsuzawa, I. Shimomura, and R.J. Heine Prognostic value of adiponectin for cardiovascular disease and mortality J. Clin. Endocrinol. Metab. 93 2008 1489 1496
30. M. Kumada, S. Kihara, S. Sumitsuji, T. Kawamoto, S. Matsumoto, N. Ouchi, Y. Arita, Y. Okamoto, I. Shimomura, H. Hiraoka, T. Nakamura, T. Funahashi, and Y. Matsuzawa Association of hypoadiponectinemia with coronary artery disease in men Arterioscler. Thromb. Vasc. Biol. 23 2003 85 89
31. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, and E.B. Rimm Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737
32. Y. Seino, H. Hirose, I. Saito, and H. Itoh High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men Metab. Clin. Exp. 58 2009 355 360